BALCX
Price
$35.42
Change
-$0.04 (-0.11%)
Updated
Jun 5 closing price
Net Assets
243.43B
JABAX
Price
$47.26
Change
-$0.08 (-0.17%)
Updated
Jun 5 closing price
Net Assets
25.07B
Interact to see
Advertisement

BALCX vs JABAX

Header iconBALCX vs JABAX Comparison
Open Charts BALCX vs JABAXBanner chart's image
American Funds American Balanced C
Price$35.42
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets243.43B
Janus Henderson Balanced T
Price$47.26
Change-$0.08 (-0.17%)
VolumeN/A
Net Assets25.07B
BALCX vs JABAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. JABAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and JABAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 243B vs. JABAX (25.1B). JABAX pays higher dividends than BALCX: JABAX (1.80) vs BALCX (1.24). BALCX was incepted earlier than JABAX: BALCX (24 years) vs JABAX (33 years). BALCX (1.31) is less costly to investors than JABAX (0.82). JABAX is a more actively managed with annual turnover of: 76.00 vs. BALCX (44.00). BALCX has a lower initial minimum investment than JABAX: BALCX (250) vs JABAX (2500). BALCX annual gain was more profitable for investors over the last year : 6.16 vs. JABAX (5.23). JABAX return over 5 years is better than : 38.89 vs. BALCX (30.52).
BALCXJABAXBALCX / JABAX
Total Expense Ratio1.310.82160%
Annual Report Gross Expense Ratio1.310.82160%
Fund Existence24 years33 years-
Gain YTD4.2804.141103%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets243B25.1B968%
Annual Yield % from dividends1.241.8069%
Returns for 1 year6.165.23118%
Returns for 3 years20.8625.8381%
Returns for 5 years30.5238.8978%
Returns for 10 years52.6779.5566%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRK20.680.28
+1.37%
A-Mark Precious Metals
ENTA7.200.09
+1.27%
Enanta Pharmaceuticals
XP19.780.20
+1.02%
XP
GTBP2.700.01
+0.42%
GT Biopharma
IIPR54.78-0.56
-1.01%
Innovative Industrial Properties